Position in ALEC
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$74,230
-$66,337 QoQ
Shares Held
34,526
-61.7% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,435,833 across 390 Biotechnology names. ALEC ranks #233 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ALEC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $74,230 | 34,526 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $140,567 | 90,108 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $155,177 | 52,425 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $70,840 | 50,601 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $48,504 | 39,435 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $71,755 | 37,966 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $117,957 | 25,313 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $118,465 | 26,094 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $131,711 | 21,879 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $133,209 | 16,693 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $303,756 | 46,876 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $331,625 | 55,179 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $329,970 | 53,307 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $18 | 2 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $34,858 | 3,685 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $71,992 | 7,086 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $955,262 | 67,036 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,751,737 | 84,830 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $988,629 | 43,323 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $60,760 | 2,917 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $115,985 | 5,759 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,220,853 | 80,691 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $208,380 | 19,780 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $584,823 | 23,929 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,433,200 | 59,395 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||